Disease Areas
Veracyte Aims to Broaden Reach of Decipher Prostate Assay as Studies Continue to Expand Utility
Premium
The company reported significant momentum in test volumes for the second quarter of this year as new publications shore up utility evidence and open new applications.
Veracyte Q2 Revenues More Than Double on Test Volume Spike
The company's commercial test volume and test revenues were both up more than 200 percent compared to the same quarter last year.
Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project
The firm will provide testing using its HCCscreen assay and help develop follow-up procedures as part of an effort to advance cancer early detection in rural areas of China.
Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests
Both tests run on any of the firm's GeneXpert systems and add second targets for HIV detection and early identification.
The company has used RNA sequencing to discover its marker set but plans to transition the assay to a PCR platform before it seeks regulatory clearance.
Jul 22, 2021
Jul 22, 2021
CDC Updates STI Diagnosis, Treatment Guidelines
Jul 21, 2021
Jul 14, 2021
Sera Prognostics Goes Public With $75M IPO
Jul 14, 2021